Dr. Reddy’s CFO M.V. Narasimham recognized as Best CFO in Pharmaceuticals for 2026
The award was conferred at the 9th BW CFO World’s Best CFO & Finance Strategy Excellence Award 2026, hosted by Businessworld
Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, today announced that its Chief Financial Officer (CFO) M. V. Narasimham has been bestowed with 'Best CFO in Pharmaceuticals' honour at the 9th BW CFO World's Best CFO & Finance Strategy Excellence Awards 2026, hosted by Businessworld. This recognition highlights Narasimham’s strong contribution to building a robust and agile finance function at Dr. Reddy’s, along with supporting the company’s long-term stability and growth.
A Chartered Accountant by qualification, Narasimham has been an integral part of Dr. Reddy’s since 2000, holding several key positions across global finance functions. Prior to his current role as the company’s CFO, he served as Deputy CFO, where he led global commercial business finance and taxation across multiple geographies.
Commenting on the recognition, M. V. Narasimham, Chief Financial Officer, Dr. Reddy's Laboratories said: " I’m truly delighted to receive this award. It is a testament to the strength of our team and our shared commitment to excellence. At Dr. Reddy’s, we continue to strengthen our financial foundation while enabling strategic growth, innovation and resilience in a dynamic global environment, while staying aligned with our purpose of serving patient needs.”
The 9th Annual BW CFO World's Best CFO & Finance Strategy Excellence Awards 2026 recognizes finance leaders who have demonstrated exceptional strategic thinking, financial stewardship and innovation across industries.
